Drug intelligence / Profile preview

hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Topical
01

Overview

Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate is a marketed topical combination drug composed of a corticosteroid and two antibacterial small molecules. In the cream formulation marketed as **Cortisporin**, hydrocortisone acetate 0.5% provides local anti-inflammatory activity through glucocorticoid receptor agonism, while neomycin sulfate and polymyxin b sulfate provide broad topical antibacterial coverage against susceptible organisms, including gram-positive and gram-negative bacteria such as *Staphylococcus aureus*, *Escherichia coli*, *Haemophilus influenzae*, *Klebsiella/Enterobacter* species, *Neisseria* species, and *Pseudomonas aeruginosa*. It is used primarily for corticosteroid-responsive dermatoses with secondary infection or risk of infection, and is an approved, marketed pharmaceutical available in topical cream form; related neomycin/polymyxin/hydrocortisone products also exist in otic and ophthalmic presentations, but those are distinct formulations from the exact hydrocortisone acetate cream combination.

Brand names
Cortisporin
Other names
hydrocortisone acetate + neomycin sulfate + polymyxin bneomycin sulfate + polymyxin b sulfate + hydrocortisone acetate
02

Targets

LPS/OM (Gram-negative bacterial outer membrane lipopolysaccharide-lipid A layer)Bacterial RibosomeGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call